Making
Hope Real.
Making
Hope Real.
The vision of the Snowdome Foundation is to ensure every Australian blood cancer
patient has the best opportunity for a cure, and this starts with a correct diagnosis.
We collaborate with world-leading Australian blood cancer researchers, both at home and overseas,
to accelerate new therapies and bring next-generation treatments to patients, faster.
We are the leading not-for-profit organisation focused exclusively on raising funds to
support translational research and clinical trials that will accelerate new treatments
(and cures) to help Australian blood cancer patients live longer, better lives.
Enabled more than $95 million to be invested in blood cancer research since 2010.
84 research projects funded enabling over 105 research positions.
Over 6,500 subsidised genomic tests completed at the Wilson Centre for Blood Cancer Genomics.
Enabled thousands of patients to participate in over 125 clinical trials.
Latest News
Funding Extension Announced for World-First B-cell Lymphoma Research
Snowdome Foundation has committed to a further two years of funding for world-first research led by Dr Adrian Minson at the Peter MacCallum Cancer Centre, aimed at optimising immunotherapy for aggressive B-cell lymphomas.
Read more
Research Update: Inaugural Snowdome Haematology Fellowship
Research undertaken as part of the inaugural Snowdome Haematology Fellowship, awarded to Dr Josh Tobin in 2022 is set to have a transformative impact on frontline treatment for follicular lymphoma, offering more personalised, safer and effective treatment.
Read more
2025 Cannon Family Travel Grant Awardees
The Snowdome Foundation congratulates Dr Paniz Tavakoli and Dr Helen Cashman who have been announced as the 2025 Cannon Family Travel Grant recipients.
Read moreSign up to receive the latest Snowdome news.
